Posted by Michael Wonder on 17 Feb 2022
Agios wins FDA approval for pill to treat rare blood disease
17 February 2022 - The Cambridge company’s CEO says it has the potential to become a blockbuster drug.
Federal regulators have approved the first medicine for people with pyruvate kinase deficiency, a rare blood disorder.
